Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002934 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ
A Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
- Terminated
- Registry status
- Phase 2
- Development phase
- 711
- Enrollment target
NCT00002934 is a Phase 2 study that was terminated before completion, run by Eastern Cooperative Oncology Group. The registered enrollment target is 711 participants.
The verdict
NCT00002934, a Phase 2 study, was terminated before completion, sponsored by Eastern Cooperative Oncology Group.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 711 participants
- Enrollment target
Study Summary
RATIONALE: The evaluation of breast cancer recurrence rates may improve the ability to plan cancer treatment for patients with breast cancer. PURPOSE: Study to evaluate the rate of recurrence of breast cancer in women who have had surgery for ductal carcinoma in situ.
Interventions
- PROCEDURE long-term screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 711 participants |
| Start Date | 1997-06-25 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002934
The ClinicalTrials.gov registry entry for NCT00002934 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 711 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which long-term screening is the first listed.
NCT00002934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002934 about?
NCT00002934 is a clinical study titled "Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ". RATIONALE: The evaluation of breast cancer recurrence rates may improve the ability to plan cancer treatment for patients with breast cancer. PURPOSE: Study to evaluate the rate of recurrence of breast cancer in women who have had surgery for ductal carcinoma in situ.
What is the current status of trial NCT00002934?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 711 participants. The study started on 1997-06-25. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00002934?
The interventions under investigation include: long-term screening (PROCEDURE).
Who is sponsoring clinical trial NCT00002934?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.